Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Gateway for Cancer Research"
Count: 46
Selected: 0
NCT IDTitle
NCT03194932Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage
NCT01713400Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
NCT06200155Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
NCT06263153Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
NCT05669846Responder-derived FMT (R-FMT) and Pembrolizumab in Relapsed/Refractory PD-L1 Positive NSCLC
NCT05101551Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
NCT04416568Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
NCT05458284The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment
NCT04580446HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer
NCT02482376Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
NCT02482389Study of Preoperative Boost Radiotherapy
NCT01861002A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
NCT00578396Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention
NCT01848457Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
NCT02296671Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
NCT00519545Prayer as a Possible Adjuvant Treatment for Breast Cancer
NCT02553460Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
NCT01823991COGNUTRIN in Breast Cancer Survivors
NCT03006848A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
NCT02754752Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment
NCT05053750TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT03657576Trial of C134 in Patients With Recurrent GBM
NCT06268015Botensilimab and Balstilimab Optimization in Colorectal Cancer
NCT04883671Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
NCT03093909Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
NCT05029999CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
NCT06030037Pembrolizumab/Lenvatinib With and Without Responder-derived FMT in Relapsed/Refractory Melanoma
NCT05030441Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
NCT03446638iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
NCT04397003Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
NCT04483206Personalized Autologous Transplant for Multiple Myeloma
NCT03587740ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
NCT05318469Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer
NCT01852890Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
NCT02530125Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission
NCT02109627Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML
NCT01201694Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)
NCT02435550iCare for Cancer Patients
NCT04898894Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
NCT01591356EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
NCT0471672568Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
NCT02344355A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
NCT00668707Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality
NCT05721248STOP-HER2: Stopping Trastuzumab in HER2+ MBC
NCT01067287Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
NCT05292664Venetoclax Basket Trial for High Risk Hematologic Malignancies